Agilent Technologies, Inc. (NYSE:A) Given Average Recommendation of “Moderate Buy” by Brokerages

Agilent Technologies, Inc. (NYSE:A) has been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are presently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $148.6923.

A has been the topic of several research reports. UBS Group upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the company from $130.00 to $170.00 in a research note on Wednesday. Evercore ISI boosted their target price on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday. Wells Fargo & Company boosted their target price on Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, September 15th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday. Finally, Barclays upped their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd.

Agilent Technologies Trading Down 2.5%

NYSE:A opened at $136.62 on Friday. Agilent Technologies has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The stock has a market capitalization of $38.73 billion, a PE ratio of 32.07, a price-to-earnings-growth ratio of 4.57 and a beta of 1.26. The business’s 50-day simple moving average is $125.04 and its 200-day simple moving average is $117.05.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts expect that Agilent Technologies will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Institutional Investors Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently made changes to their positions in the stock. Capital A Wealth Management LLC raised its stake in shares of Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares in the last quarter. Stone House Investment Management LLC bought a new stake in shares of Agilent Technologies during the 1st quarter worth approximately $30,000. Opal Wealth Advisors LLC bought a new stake in shares of Agilent Technologies during the 1st quarter worth approximately $31,000. Ransom Advisory Ltd acquired a new position in shares of Agilent Technologies during the 1st quarter worth approximately $32,000. Finally, Central Pacific Bank Trust Division acquired a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $33,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.